IR-Med, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that IR-Med, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q2 | 2025 | Jun 30, 2025 | ($701.0K) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($773.0K) | May 15, 2025 |
| Q3 | 2024 | Sep 30, 2024 | ($598.0K) | Nov 14, 2024 |
| Q2 | 2025 | Jun 30, 2024 | ($366.0K) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($657.0K) | May 15, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($1.18M) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.11M) | Aug 13, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.35M) | May 13, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($856.0K) | Nov 14, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($939.0K) | Aug 14, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($849.0K) | May 15, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($730.0K) | Nov 14, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($1.52M) | Aug 15, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($444.0K) | May 16, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($89.0K) | Nov 15, 2021 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q2 | 2025 | Jun 30, 2025 | ($286.0K) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($253.0K) | May 15, 2025 |
| Q3 | 2024 | Sep 30, 2024 | ($601.0K) | Nov 14, 2024 |
| Q2 | 2025 | Jun 30, 2024 | ($358.0K) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($658.0K) | May 15, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($1.20M) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.10M) | Aug 13, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.35M) | May 13, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($876.0K) | Nov 14, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($971.0K) | Aug 14, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($853.0K) | May 15, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($722.0K) | Nov 14, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($1.52M) | Aug 15, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($431.0K) | May 16, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($80.0K) | Nov 15, 2021 |